thiotepa has been researched along with Theca Cell Tumor in 3 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rybalka, AN | 1 |
| Mardakhiashvili, ShI | 2 |
3 other studies available for thiotepa and Theca Cell Tumor
| Article | Year |
|---|---|
[Repeat surgery for recurring thecoma of the ovary].
Topics: Androgens; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Thecoma; Thio | 1967 |
[On the prevention of postoperative recurrences in cancer of the ovaries].
Topics: Adult; Cyclophosphamide; Cystadenoma; Dysgerminoma; Female; Granulosa Cell Tumor; Humans; Middle Age | 1968 |
[Comparative evaluation of methods of treatment of early stages of malignant ovarian neoplasms].
Topics: Adult; Cyclophosphamide; Cystadenoma; Dysgerminoma; Female; Humans; Melphalan; Middle Aged; Ovarian | 1968 |